Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients

GUIDELINE TITLE
Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?

BIBLIOGRAPHIC SOURCE(S)
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan. Genet Med 2009 Jan;11(1):15-20. PubMed

GUIDELINE STATUS
This is the current release of the guideline.

abrir aquí para acceder al documento AHRQ NGC completo:
Recommendations from the EGAPP Working Group: can <em>UGT1A1</em> genotyping reduce morbidity and mortality in patients